Oxycodone hydrochloride and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone hydrochloride (oxycodone hydrochloride) and Keppra (levetiracetam). Common drug interactions include lower respiratory tract infection among females and blood pressure increased among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone hydrochloride and Keppra. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone hydrochloride?

Oxycodone hydrochloride has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 36,817 Oxycodone hydrochloride users. Check the latest studies of Oxycodone hydrochloride.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 12, 2026

78 people who take Oxycodone hydrochloride and Keppra together, and have interactions are studied.

Oxycodone hydrochloride and Keppra drug interactions.

What are the common drug interactions of Oxycodone Hydrochloride and Keppra, by gender? *:

female:

  1. Lower respiratory tract infection
  2. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  5. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Pleuritic pain
  9. Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
  10. Pyuria (a condition of urine containing pus)

male:

  1. Blood pressure increased
  2. Urinary tract infection
  3. Benign prostatic hyperplasia (benign enlargement of the prostate)
  4. Body temperature decreased
  5. Cardiac failure congestive
  6. Catheter site haemorrhage (bleeding at catheter site)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Cough
  10. Death

What are the common drug interactions of Oxycodone Hydrochloride and Keppra, by age (0-1 to 60+)? *:

0-1:

  1. Body temperature decreased
  2. Catheter site haemorrhage (bleeding at catheter site)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Cough
  5. Death
  6. Dyspnoea (difficult or laboured respiration)
  7. Ear infection
  8. Erythema (redness of the skin)
  9. Furuncle (infection of the hair follicle)
  10. Heart rate decreased

2-9:

n/a

10-19:

  1. Abdominal pain
  2. Balance disorder
  3. Constipation
  4. Death
  5. Dehydration (dryness resulting from the removal of water)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Nausea (feeling of having an urge to vomit)
  8. Renal cyst (kidney cyst)
  9. Vomiting

20-29:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Dizziness
  3. Drug hypersensitivity
  4. Drug ineffective
  5. Erythema (redness of the skin)
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hypotension (abnormally low blood pressure)
  10. Malaise (a feeling of general discomfort or uneasiness)

30-39:

  1. Completed suicide (act of taking one's own life)
  2. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  3. Arthralgia (joint pain)
  4. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  5. Dry skin
  6. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

40-49:

  1. Leukocytosis (increased white blood cells)
  2. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  3. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  6. Muscle spasms (muscle contraction)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Pleuritic pain
  9. Pyuria (a condition of urine containing pus)
  10. Swelling

50-59:

  1. Chest pain
  2. Cough
  3. Dizziness
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Expressive language disorder
  7. Fatigue (feeling of tiredness)
  8. Fibrin d dimer increased
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Insomnia (sleeplessness)

60+:

  1. Pneumonia
  2. Blood pressure increased
  3. Rib fracture
  4. Traumatic lung injury
  5. Drug dependence
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Overdose
  8. Abdominal pain
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 14.10%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 14.10%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 10.26%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 5.13%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.13%
  6. Immunodeficiency Common Variable: 4 people, 5.13%
  7. Drowsiness: 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone hydrochloride and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxycodone hydrochloride and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxycodone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and levetiracetam (the active ingredients of Oxycodone hydrochloride and Keppra, respectively), and Oxycodone hydrochloride and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: